This week marked a pivotal advancement for people with extensive-stage small cell lung cancer (ES-SCLC).

Amgen 🧪🔬🧬’s allies at LUNGevity Foundation & LCRF share how approval of our Bispecific T-cell Engager (BiTE®) immunotherapy is igniting hope in the ES-SCLC community 👇

Oncologists may soon have a new weapon in their arsenal to attack small cell lung cancer.

Amgen 🧪🔬🧬 developed a potential targeted therapy that empowers a patient’s own immune system to seek out and help fight cancer cells.

🔗Learn more: amgen.ly/4ap88RU

🔬Innovation is here for people with extensive-stage small cell lung cancer (ES-SCLC).

Amgen 🧪🔬🧬 discovered a new way to target and attack ES-SCLC – one that empowers a patient’s own immune cells to join the fight.

There’s a new way to target & attack small cell lung cancer ( #SCLC ).

GO2 for Lung Cancer’s Laurie Fenton Ambrose reflects on what Amgen 🧪🔬🧬’s innovation means to the SCLC community.

🔗Learn more about yesterday's FDA approval: amgen.ly/4dH199M

The U.S. FDA has approved Amgen’s treatment for adults with extensive-stage small cell lung cancer (ES-SCLC).

This option is the first BiTE ® therapy for ES-SCLC.

🔗 Press release: amgen.ly/4blqtR1

$AMGN

Like Lindy & Pamela, about 2 out of 3 people with small cell lung cancer ( #SCLC ) have extensive disease when their cancer is first found.
At Amgen 🧪🔬🧬, we are determined to expand treatment possibilities & bring hope to people with this aggressive disease. Explore our research ⬇️

Over the weekend patients, survivors and caregivers from across the country convened in Atlanta for LUNGevity Foundation’s annual #HOPESummit , a unique event dedicated to living well with lung cancer. Amgen 🧪🔬🧬 was honored to be part of #ThisIsHope24 .

🔗Learn more: amgen.ly/3Ww7bnn

🔬Oncology #research has the power to change lives. From biomarker-based targeted therapies to novel combination approaches, Amgen 🧪🔬🧬 pioneers meaningful research in tough-to-treat cancers with high unmet needs.

🔗 Explore our diverse pipeline: amgen.ly/3WrVWN0 #NCRM24

It is a BIG day for cancer patients in Iowa! Gov. Kim Reynolds Kim Reynolds just signed the biomarker testing bill into law requiring more insurance plans to cover this game changing testing. Thank you, Governor Reynolds! #IALegis #ACSCAN

How can we personalize gastric cancer care?
At Amgen 🧪🔬🧬, we’re exploring the full potential of #FGFR2b as a target 🎯 for new therapies.
🔗Learn more about FGFR2b: amgen.ly/3UbMomz

Cancer is deeply personal, and cancer care should be, too.

Through our science and understanding of the unique biology underlying each person and each cancer, we aim to expand treatment possibilities.

🔗 Discover how: amgen.ly/3vPPg08

This #LabWeek , join us in celebrating the dedicated medical laboratory professionals & pathologists around the world whose expertise is indispensable for people with cancer.

We thank you for your tremendous contributions to patient care!🔬🧪

B-cells are antibody-producing white blood cells that help protect the body from infection-causing pathogens and diseases. Abnormal B-cell development is associated with the most common form of acute lymphoblastic leukemia (ALL), B-cell precursor ALL.

Fact: Black Americans with #lungcancer experience poorer outcomes than their white counterparts.

HEAL Collaborative works to eliminate healthcare disparities by communicating accurate info to empower people to get the care they deserve: amgen.ly/3Jg9G5B #MinorityHealthMonth

Have you heard of #KRASG12C ?

This genetic mutation is a major driver of cancer growth, found in non-small cell lung cancer & metastatic colorectal cancer.

➡️ Discover the facts about this biomarker:

Knowing your cancer’s specific #biomarkers helps you and your healthcare team identify treatment options – now and in the future.
Learn about the role of biomarkers in gastric cancer treatment planning 🔗 amgen.ly/4cJtImn #AmgenSponsored

At Amgen 🧪🔬🧬, we harness the power of science to take on cancer’s toughest challenges.

In small cell lung cancer ( #SCLC ), we’re working to bring patients’ own T cells to the fight. Learn about our investigational immunotherapy at amgen.ly/3x1sUJ6

What should you do if you or a loved one is diagnosed with acute lymphoblastic leukemia ( #ALL )🩸?

The Leukemia & Lymphoma Society provides patients & caregivers with empowering information that can help people receive the support they need.

➡️ Learn more:

1 in 23 men and 1 in 25 women will be diagnosed with colorectal cancer ( #CRC ) in their lifetime. We are proud to support Fight Colorectal Cancer and their efforts to #PrioritizeCRC throughout #ColorectalCancerAwarenessMonth and beyond. #AmgenSponsored

Congratulations to Amgen’s soria on his election to the AACR Board of Directors! 👏

Jean-Charles will lend his expertise in precision medicine and immuno-oncology to help guide Association policy and advance cancer research. Click to learn more 🔗 amgen.ly/4cmnlFA